Laird GM - Search Results

1

Distinct viral reservoirs in individuals with spontaneous control of HIV-1.

Jiang C, Lian X, Gao C, Sun X, Einkauf KB, Chevalier JM, Chen SMY, Hua S, Rhee B, Chang K, Blackmer JE, Osborn M, Peluso MJ, Hoh R, Somsouk M, Milush J, Bertagnolli LN, Sweet SE, Varriale JA, Burbelo PD, Chun TW, Laird GM, Serrao E, Engelman AN, Carrington M, Siliciano RF, Siliciano JM, Deeks SG, Walker BD, Lichterfeld M, Yu XG. Jiang C, et al. Among authors: laird gm. Nature. 2020 Sep;585(7824):261-267. doi: 10.1038/s41586-020-2651-8. Epub 2020 Aug 26. Nature. 2020. PMID: 32848246 Free PMC article.

2

A novel PCR assay for quantification of HIV-1 RNA.

Shan L, Rabi SA, Laird GM, Eisele EE, Zhang H, Margolick JB, Siliciano RF. Shan L, et al. Among authors: laird gm. J Virol. 2013 Jun;87(11):6521-5. doi: 10.1128/JVI.00006-13. Epub 2013 Mar 27. J Virol. 2013. PMID: 23536672 Free PMC article.

3

Rapid quantification of the latent reservoir for HIV-1 using a viral outgrowth assay.

Laird GM, Eisele EE, Rabi SA, Lai J, Chioma S, Blankson JN, Siliciano JD, Siliciano RF. Laird GM, et al. PLoS Pathog. 2013;9(5):e1003398. doi: 10.1371/journal.ppat.1003398. Epub 2013 May 30. PLoS Pathog. 2013. PMID: 23737751 Free PMC article. Clinical Trial.

4

Multi-step inhibition explains HIV-1 protease inhibitor pharmacodynamics and resistance.

Rabi SA, Laird GM, Durand CM, Laskey S, Shan L, Bailey JR, Chioma S, Moore RD, Siliciano RF. Rabi SA, et al. Among authors: laird gm. J Clin Invest. 2013 Sep;123(9):3848-60. doi: 10.1172/JCI67399. Epub 2013 Aug 27. J Clin Invest. 2013. PMID: 23979165 Free PMC article.

5

A novel cell-based high-throughput screen for inhibitors of HIV-1 gene expression and budding identifies the cardiac glycosides.

Laird GM, Eisele EE, Rabi SA, Nikolaeva D, Siliciano RF. Laird GM, et al. J Antimicrob Chemother. 2014 Apr;69(4):988-94. doi: 10.1093/jac/dkt471. Epub 2013 Nov 24. J Antimicrob Chemother. 2014. PMID: 24275119 Free PMC article.

6

New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo.

Bullen CK, Laird GM, Durand CM, Siliciano JD, Siliciano RF. Bullen CK, et al. Among authors: laird gm. Nat Med. 2014 Apr;20(4):425-9. doi: 10.1038/nm.3489. Epub 2014 Mar 23. Nat Med. 2014. PMID: 24658076 Free PMC article.

7

Measuring reversal of HIV-1 latency ex vivo using cells from infected individuals.

Ho YC, Laird GM, Siliciano RF. Ho YC, et al. Among authors: laird gm. Proc Natl Acad Sci U S A. 2014 May 13;111(19):6860-1. doi: 10.1073/pnas.1405194111. Epub 2014 May 5. Proc Natl Acad Sci U S A. 2014. PMID: 24799684 Free PMC article. No abstract available.

8

Ex vivo analysis identifies effective HIV-1 latency-reversing drug combinations.

Laird GM, Bullen CK, Rosenbloom DI, Martin AR, Hill AL, Durand CM, Siliciano JD, Siliciano RF. Laird GM, et al. J Clin Invest. 2015 May;125(5):1901-12. doi: 10.1172/JCI80142. Epub 2015 Mar 30. J Clin Invest. 2015. PMID: 25822022 Free PMC article.

9

Medroxyprogesterone acetate increases HIV-1 infection of unstimulated peripheral blood mononuclear cells in vitro.

Sampah ME, Laird GM, Blankson JN, Siliciano RF, Coleman JS. Sampah ME, et al. Among authors: laird gm. AIDS. 2015 Jun 19;29(10):1137-46. doi: 10.1097/QAD.0000000000000681. AIDS. 2015. PMID: 26035316 Free PMC article.

10

Measuring the Frequency of Latent HIV-1 in Resting CD4⁺ T Cells Using a Limiting Dilution Coculture Assay.

Laird GM, Rosenbloom DI, Lai J, Siliciano RF, Siliciano JD. Laird GM, et al. Methods Mol Biol. 2016;1354:239-53. doi: 10.1007/978-1-4939-3046-3_16. Methods Mol Biol. 2016. PMID: 26714716

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

42 results

Search Page